Impact of oral administration of single strain lactococcus lactis spp. cremoris on immune responses to keyhole limpet hemocyanin immunization and gut microbiota: a randomized placebo-controlled trial in healthy volunteers

HIGHLIGHTS

• who: Mahdi Saghari from the Oslo University HospitalNetherlands, Evelo Biosciences Inc, Cambridge, MA, United States have published the article: Impact of oral administration of single strain Lactococcus lactis spp. cremoris on immune responses to keyhole limpet hemocyanin immunization and gut microbiota: A randomized placebo-controlled trial in healthy volunteers, in the Journal: (JOURNAL)
• what: The aim of this study was to investigate the pharmacodynamic (PD) effects of three monoclonal microbial formulations of L lactis spp. cremoris (EDP1066) on the immune_response to keyhole limpet hemocyanin (KLH). The authors aimed at assessing the impact of EDP1066 on . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.